SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,416,415 | -25.4% | 5,883,693 | 0.0% | 1.10% | -24.6% |
Q2 2023 | $27,359,172 | +4.1% | 5,883,693 | +3.4% | 1.46% | +31.8% |
Q1 2023 | $26,283,577 | -41.5% | 5,689,086 | +2.2% | 1.11% | -41.2% |
Q4 2022 | $44,966,000 | +61.4% | 5,565,099 | +10.9% | 1.89% | +63.3% |
Q3 2022 | $27,861,000 | +15.1% | 5,020,000 | +8.1% | 1.16% | +25.8% |
Q2 2022 | $24,200,000 | -21.1% | 4,645,000 | +24.5% | 0.92% | -1.8% |
Q1 2022 | $30,680,000 | -15.4% | 3,732,400 | +53.1% | 0.94% | +33.5% |
Q4 2021 | $36,274,000 | -14.0% | 2,437,795 | +9.1% | 0.70% | -1.3% |
Q3 2021 | $42,194,000 | +32.3% | 2,233,695 | +30.2% | 0.71% | +49.1% |
Q2 2021 | $31,889,000 | +9.0% | 1,715,381 | +33.5% | 0.48% | +10.2% |
Q1 2021 | $29,246,000 | +30.1% | 1,284,976 | +24.1% | 0.43% | +34.9% |
Q4 2020 | $22,479,000 | +91.1% | 1,035,409 | -11.5% | 0.32% | +51.4% |
Q3 2020 | $11,760,000 | +67.9% | 1,170,166 | +29.6% | 0.21% | +40.4% |
Q2 2020 | $7,006,000 | +748.2% | 902,800 | +1014.6% | 0.15% | +586.4% |
Q1 2020 | $826,000 | – | 81,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |